Latest Breaking News On - Food beverages to pharmaceuticals - Page 1 : comparemela.com

LC-Plasma-based Vaccine Research Selected for SCARDA Project

LC-Plasma-based Vaccine Research Selected for SCARDA Project
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Tetsuro matanoDaisuke fujiwaraKirin holdingsKirin holdings companyHealth scienceStrategic centerHealth science instituteDevelopment for preparednessFood beverages to pharmaceuticalsJapan agency for medical researchResearch developmentBiomedical advanced vaccine researchKirin group visionKirin groupNational institute of infectious diseasesNational institute

Kirin iMUSE Immune Care and Healthya Visceral Fat Down will go on sale on Tuesday November 28

Kirin Holdings Company Limited TOKYO2503 will launch a dualcare functional food supplement Kirin iMUSE ImmunoCare and Healthya Visceral Fat Down on November 28 Tuesday.

Kao healthyaKoiwai nyugyoKyowa hakko bioKao corporationKirin holdings companyKirin groupKirin group visionJapan medical abstracts societyNational commendation for inventionHealth scienceFood for specified health use tokuhoFood for specified healthCompanies to address healthConsumer affairs agencyFood beverages to pharmaceuticalsWakayama health promotion study

Kirin iMUSE Immune Care and Healthya Visceral Fat Down will go on sale on Tuesday, November 28!

A special dual-care functional food product from iMUSE, our immune care brand, and Healthya, a visceral fat care brand .

Koiwai nyugyoKao healthyaKyowa hakko bioKirin holdingsCompanies to address healthConsumer affairs agencyFood beverages to pharmaceuticalsHealth scienceFood for specified healthFood for specified health use tokuhoKirin group visionKao corporationFoods for specified healthKirin groupJapan medical abstracts societyNational commendation for invention

Japan s First Discovery*1 on Visceral Fat and Immune Activity in Joint Research by Kirin Holdings and Kao | National Business

TOKYO (BUSINESS WIRE) Nov 24, 2023

Nakano kuUnited statesChuo kuClin nutrJohn friedaMolton brownNihonbashi kayabachoResearch methodsCollaborative researchKirin groupSociety webCorporate communication departmentFood beverages to pharmaceuticalsWakayama health promotion studyKirin holdings companyKirin holdings

Japan s First Discovery*1 on Visceral Fat and Immune Activity in Joint Research by Kirin Holdings and Kao

- Kirin Holdings Company, Limited (TOKYO:2503) and Kao Corporation (TOKYO:4452) will participate in the Wakayama Health Promotion Study, a cohort study 2 led .

Nakano kuChuo kuUnited statesNihonbashi kayabachoClin nutrMolton brownJohn friedaCorporate communication departmentSociety webResearch methodsBusiness wire kirin holdings companyJournal of health careKirin groupHealth scienceFood beverages to pharmaceuticalsKirin holdings company